International Travel Health Precautions for Children

By Travelog Editorial Team · Updated August 9, 2026

Beyond vaccines, CDC's pediatric travel-health guidance covers four areas with specific, weight- or age-based rules: malaria prevention medication is dosed by body weight and varies by drug (doxycycline only from age 8, others from any age), traveler's diarrhea in children is treated primarily with oral rehydration solution since no US-licensed vaccine exists for it, DEET insect repellent is approved for children as young as 2 months, and children get altitude sickness as often as adults but often show it only as unexplained fussiness, not a headache complaint.

Vaccines cover one category of pre-travel medical planning for kids, but they're not the only one, and treating them as the whole checklist misses three areas where CDC guidance is just as specific: what to actually do about malaria risk, how to handle the diarrhea that international travel makes more likely, and which insect repellent is actually safe to use on an infant.

Malaria Prevention Is Dosed by Weight, Not by a Flat Child Dose

For destinations with genuine malaria risk, CDC guidance is explicit that pediatric prophylaxis dosing is calculated by body weight, not a simplified "half the adult dose" approximation. Which specific medication is even an option depends on the child's age: chloroquine, mefloquine, and primaquine can be given to children of any age, atovaquone-proguanil is approved from 5 kilograms of body weight, doxycycline only from age 8, and tafenoquine only from age 18 -- meaning a family traveling with a child under 8 has a meaningfully narrower set of options than a family traveling with a teenager, and the standard advice for adult travelers doesn't automatically apply.

Two more practical details matter here. First, primaquine and tafenoquine both require G6PD testing before use, since these medications shouldn't be given for malaria prevention to someone with G6PD deficiency -- a specific medical screening step, not a formality. Second, several of the pediatric-approved medications (atovaquone-proguanil, chloroquine, mefloquine) have a genuinely bitter taste that makes them hard to get a young child to take; CDC guidance notes that mixing pulverized tablets into a small amount of food or drink helps, and that compounding pharmacists can prepare calculated pediatric doses as gelatin capsules for families who need that option. All malaria medication should be stored in childproof containers, out of reach of children -- a safety note given these are genuine prescription medications carried on a family trip, not vitamins.

Traveler's Diarrhea: Why Rehydration, Not Medication, Is the Front Line

This is a case where the honest answer runs against instinct: there is no vaccine licensed in the United States to prevent traveler's diarrhea in children, which means food and water precautions are, per CDC's own framing, the single most important preventive measure available -- not a backup plan behind a shot.

When diarrhea or vomiting does happen, the actual danger for an infant or young child is dehydration, and oral rehydration solution (ORS) is the front-line treatment CDC recommends, ahead of medication. ORS is a specific product -- prepackaged glucose-and-electrolyte packets available at pharmacies in nearly every country, mixed with boiled, treated, or bottled water -- not a euphemism for "give them fluids." A breastfed infant should keep breastfeeding through an illness alongside ORS, and starting rehydration early, before dehydration is visibly severe, is what actually prevents the situation from escalating.

Prevention itself comes down to specific water practices: using purified water for drinking, making ice, brushing teeth, and mixing infant formula or food. For infants under 3 months old, or any child with a weakened immune system, CDC guidance gets even more specific -- reconstitute powdered formula using water heated to at least 70°C (roughly 158°F), then let it cool before feeding, since that temperature threshold is what's actually needed to address contamination risk in the water itself, not just general caution.

DEET Is Approved for Infants as Young as 2 Months, at a Specific Concentration

Insect-borne disease is a genuine part of the risk picture for a lot of international destinations, and here CDC and the American Academy of Pediatrics have a shared, specific position rather than a vague "use caution" one: DEET-based repellent, at 10% to 30% concentration, is approved and supported for children older than 2 months.

The AAP goes a step further with a specific concentration recommendation, not just a range -- products at the lower end of the effective spectrum, 20% to 30% DEET, are considered the most prudent choice for infants and young children, applied sparingly rather than heavily. This is a checkable detail that's easy to get wrong in either direction: too little concentration under-protects against mosquito-borne disease risk in a genuinely high-risk destination, while reaching for a much higher concentration than necessary isn't the safer choice it might seem like.

Altitude Sickness in Kids Looks Different, and the Prevention Math Is Specific

High-altitude destinations add a distinct risk category CDC guidance treats seriously: children are just as susceptible to acute mountain sickness (AMS) as adults, but it shows up differently, and that difference is exactly what makes it easy to miss. A verbal older child might complain of a headache or shortness of breath the way an adult would. A younger child who can't yet describe symptoms often just becomes unexplainably fussy, or shows a change in appetite or sleep -- signals a parent could easily attribute to travel fatigue or a new environment rather than altitude illness.

Prevention here comes down to specific numbers rather than "take it easy." The Wilderness Medical Society's guidance, which CDC's own high-altitude chapter references, recommends avoiding a sleeping altitude of 2,750 meters (about 9,000 feet) or higher in a single day, and once above 3,000 meters (about 9,800 feet), ascending no faster than 500 meters (about 1,650 feet) of sleeping altitude per night. That's a concrete pacing plan for an itinerary, not a vague caution.

Medication is more complicated for children than for adults. Acetazolamide, the standard AMS-prevention drug, isn't approved for altitude-illness use in children under 12, even though it's considered generally safe for other pediatric uses. Some providers do prescribe it off-label for younger children when a slow-enough ascent genuinely isn't feasible for the trip, at a specific pediatric dose of 1.25 mg per kilogram of body weight every 12 hours, up to a maximum of 125 mg per dose -- a decision that belongs with a pediatrician who knows the child's health history, not a general travel guide.

A few underlying health conditions raise the stakes of high-altitude travel specifically, each for a distinct physiological reason: sickle cell disease or trait (risk of a vaso-occlusive crisis or splenic infarction at altitude), Down syndrome (airway anatomy that affects the body's hypoxic ventilatory response), cystic fibrosis (already-reduced pulmonary reserve), and thalassemia. A family managing any of these conditions has a specific reason to loop in a pediatrician before a high-altitude leg of a trip, not just a general one.

What This Means for Planning a Trip

None of these four precautions replace each other, and none of them replace the vaccine planning covered separately for this pillar -- they're parallel risk categories that a specific itinerary either does or doesn't make relevant. A trip to a malaria-endemic region needs the weight-based prophylaxis conversation with a pediatrician well before departure, given the age-based medication limits involved. Every international trip with a young child benefits from having ORS packets on hand and understanding the actual water-safety rules for formula, given how directly CDC ties diarrhea prevention to water practices rather than medication. Any destination with genuine mosquito-borne disease risk is where the DEET concentration question stops being generic parenting advice and starts being a specific, evidence-based choice. And a high-altitude leg of a trip is where symptom-recognition matters as much as prevention, since a young child's version of altitude sickness often doesn't look like an adult's.